Log In
BCIQ
Print this Print this
 

BP-2002

  Manage Alerts
Collapse Summary General Information
Company Strongbridge Biopharma plc
Description 
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today